References
-
Louis, D. N. et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 23, 1231–1251 (2021). https://academic.oup.com/neuro-oncology/article/23/8/1231/6311214
-
Wesseling, P. & Capper, D. Neuro-oncology update. Acta Neuropathol. (2022). https://pmc.ncbi.nlm.nih.gov/articles/PMC9427889/
-
Stupp, R. et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352, 987–996 (2005). https://pubmed.ncbi.nlm.nih.gov/19269895/
-
Wen, P. Y. & Packer, R. J. Neuro-oncology perspectives on CNS tumor classification. Neuro Oncol. 25 (Suppl. 4), iv1 (2023). https://academic.oup.com/neuro-oncology/article/25/Supplement_4/iv1/7289029
-
National Cancer Institute. Adult Brain Tumors Treatment (PDQ®)–Health Professional Version (2024). https://www.cancer.gov/types/brain/hp/adult-brain-treatment-pdq
-
Weller, M. et al. Glioblastoma. Nat. Rev. Dis. Primers 10, 24 (2024). https://www.nature.com/articles/s41572-024-00524-y
-
Llaguno, S. R. A. & Parada, L. F. Cell of origin of glioma: biological and clinical implications. Br. J. Cancer 115, 1445–1450 (2016). https://www.nature.com/articles/bjc2016354
-
Brennan, C. W. et al. The genomic and molecular landscape of glioblastoma. Cell 155, 462–477 (2013). https://www.cell.com/cell/fulltext/S0092-8674(13)01401-6
-
Omuro, A. & DeAngelis, L. M. Glioblastoma and other malignant gliomas: a clinical review. Nat. Rev. Neurol. 9, 393–405 (2013). https://www.nature.com/articles/nrneurol.2013.110
-
Lathia, J. D., Mack, S. C., Mulkearns-Hubert, E. E., Valentim, C. L. L. & Rich, J. N. Cancer stem cells in glioblastoma. Genes Dev. 29, 1203–1217 (2015). https://genesdev.cshlp.org/content/29/12/1203.full
-
Şakir Delil, Ş. et al. Glioblastoma cell invasion mechanisms. Cancers 14, 443 (2022). https://www.mdpi.com/2072-6694/14/2/443
-
Castillo-Ordóñez, W. O. et al. Signaling pathways altered in glioblastoma. Int. J. Mol. Sci. 25, 3040 (2024). https://www.mdpi.com/1422-0067/25/5/3040
-
Mair, M. J. et al. Molecular biomarkers and therapeutic targets in glioblastoma. Cancers 16, 3635 (2024). https://www.mdpi.com/2072-6694/16/21/3635
-
Armed Forces Institute of Pathology (AFIP). Glioblastoma radiology. Wikimedia Commons (n.d.). https://commons.wikimedia.org/wiki/File:AFIP-00405589-Glioblastoma-Radiology.jpg
-
Hupé, P. Hallmarks of cancer. Wikimedia Commons (2011). https://commons.wikimedia.org/wiki/File:Hallmarks_of_cancer.svg
-
Wikimedia contributors. Glycolysis pathway. Wikimedia Commons (2011). https://commons.wikimedia.org/wiki/File:Glycolysis.svg
-
Endo, H. Cellular dormancy mechanisms. Wikimedia Commons (n.d.). https://commons.wikimedia.org/wiki/File:Mechanisms_of_cellular_dormancy.jpg
-
Wikimedia Commons contributors. Glioblastoma MRI with gadolinium contrast. Wikimedia Commons (n.d.). https://commons.wikimedia.org/wiki/File:Glioblastoma_-_MR_sagittal_with_contrast.jpg
-
Armed Forces Institute of Pathology (AFIP). Glioblastoma radiology. Wikimedia Commons (n.d.). https://commons.wikimedia.org/wiki/File:AFIP-00405558-Glioblastoma-Radiology.jpg